Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients

American Journal of Nephrology

Volumn 19, Issue 3, 1999, Pages 383-388

  Fabrizi, Fabrizio ^a,b,c   Martin, Paul ^a   Dixit, Vivek ^a   Brezina, Maria ^a   Russell, James ^b   Conrad, Andy ^b   Schmid, Peter ^b   Gerosa, Silvia ^a   Gitnick, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Genetics Institute   (United States)

^c A MANZONI HOSPITAL   (Italy)

Author keywords

Alanine aminotransferase; Hemodialysis; Hepatitis C viremia; Hepatitis C virus incidence; Reverse transcriptase polymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROLOGY; SOUTHERN BLOTTING; VIREMIA; VIRUS GENOME;

ALANINE TRANSAMINASE; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033063578     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013482     Document Type: Article

References (49)

1. Jeffers LJ, Perez GO, De Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy KR, Jimenez M, Bourgoignie JJ, Vaamonde CA, Duncan R, Houghton M, Choo GL, Kuo G: Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990;38:320-322.
2. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV: The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990;112:958-960.
3. Esteban JH, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzales A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, Guardia J, Houghton M, Choo QL, Kuo G: Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;ii:294-297.
4. Fabrizi F, Di Filippo S, Erba G, Bacchini G, Marcelli D, Crepaldi M, Locatelli F: Hepatitis C virus infection and hepatic function in chronic hemodialysis patients. Nephron 1992; 61:119.
5. Fabrizi F, Bacchini G, Pontoriero G, Guarnori I, Erba GF, Locatelli F: Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: A study with second-generation assay. Nephrol Dial Transplant 1993;8:744-747.
6. Chaveau P, Couroucè A, Le Marrec N, Naret C, Poignet J, Girault A, Ramdane M, Delors S: Antibodies to hepatitis C virus by second-generation test in haemodialysed patients. Kidney Int 1993;43(suppl):149-152.
7. Chan TM, Lok ASF, Cheng IKPC, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993;17:135-139.
8. Carrera F, Silva G, Pires C, Oliveira C: Prevalence of non-A, non-B hepatitis and anti-HCV antibodies in a Portugal dialysis population. Nephrol Dial Transplant 1992;7:913-916.
9. Dentico P, Buongiorno R, Volpe A, Carlone A, Manno C, Proscia F, Pastore G, Schiraldi O: Prevalence and incidence of HCV in hemodialysis patients: Study of risk factors. Clin Nephrol 1992;38:49-52.
10. Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T: Hepatitis C infection in eleven Japanese hemodialysis units. Clin Nephrol 1992;38:36-43.
11. McIntyre PG, McCruden EAB, Dow BC, Cameron SO, McMillan MA, Allison MEM, Briggs JD: HCV infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 1994;9:291-295.
12. Fabrizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, Pagano A, Erba GF, Locatelli F: Serologic survey for control of hepatitis C in haemodialysis patients: Third-generation assays and analysis of costs. Nephrol Dial Transplant 1997;12:298-303.
13. Couroucè AM, Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, Naret C, Poignet JL: Hepatitis C virus infection in haemodialysed patients: HCV RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995;10:234-239.
14. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell FH, Miller RH: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993; 168:1343-1348.
15. Fernandez JL, del Pino N, Lef L, Valtuille R, Berridi J, Rendo P, Viola L: Serum hepatitis C virus RNA in anti-HCV-negative hemodialysis patients. Dial Transplant 1996;25:14-18.
16. Medin C, Allander T, Roll M, Jacobson SH, Grillner L: Seroconversion to hepatitis C virus in dialysis patients: A retrospective and prospective study. Nephron 1993;65:40-45.
17. Jadoul M, Cornu C, van Ypersele de Strihou C, UCL Collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993; 44:1322-1326.
18. Niu M, Coleman P, Alter MJ: Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993;22:568-573.
19. Lin DY, Lin HH, Huang CC, Liaw YF: High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993;21:288-291.
20. Simon N, Couroucè AM, Lemarrec N, Trepo C, Ducamp S: A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994;46:504-511.
21. Fabrizi F, Lunghi G. Guarnori I, Raffaele L, Crepaldi M, Pagano A, Locatelli F: Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant 1994;9:1611-1615.
22. Blumberg A, Zehnder C, Burckhardt JJ: Prevention of hepatitis C infection in haemodialysis units: A prospective study. Nephrol Dial Transplant 1995;10:230-233.
23. Cendoroglo Neto M, Draibe SA, Silva AE, Ferraz ML, Granato C, Pereira CA, Sesso RC, Gaspar AM, Ajzen H: Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: Evidence for environmental transmission. Nephrol Dial Transplant 1995;10:240-246.
24. Teruel JL, Pascual J, Liano F, Ortuno J: Importance of nosocomial transmission of hepatitis C virus infection in dialysis units. Clin Nephrol 1992;38:232-233.
25. Martin P, Brezina M, Dixit V, Di Nello R, Quan S, Polito A, Gitnick G: Acquisition of hepatitis C virus by hemodialysis patients (abstract). Hepatology 1993;18:93.
26. Fabrizi F, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gerosa S, Martin P, Gitnick G: Acquisition of hepatitis C virus in hemodialysis patients: A prospective study by branched DNA (bDNA) signal amplification assay. Am J Kidney Dis 1998;31:647-654.
27. Gretch D, de la Rosa C, Carithers RL, Willson RA, Williams B, Corey L: Assessment of hepatitis C viremia using amplification technologies: Correlations and clinical implications. Ann Intern Med 1995;123:321-329.
28. Urdea MS: Branched DNA signal amplification. Biotechnology 1994;12:927-928.
29. Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol 1987;155:335-350.
30. Tong MJ, Hwang SJ, Lafkowitz M, Lee SD, Co RL, Conrad A, Schmid P, Lo KJ: Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J Gastroenterol Hepatol 1994;9:587-591.
31. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH: Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995;69:459-465.
32. Yasuda K, Okuda K, Endo N, Ishiwari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y: Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology 1995;109:1295-1300.
33. Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Pagano A, Locatelli F: Influence of serum HCV RNA upon aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997;12:1394-1398.
34. Moyer LA, Alter MJ: Hepatitis C virus in the hemodialysis setting: A review with recommendations for control. Semin Dial 1994;7: 124-127.
35. + patients isolation on HCV infection incidence in a dialysis unit. Nephrol Dial Transplant 1992;7:1069-1070.
36. Robles NR, Gomez Ainsua C, Cruz A: Lack of transmission of hepatitis C virus in a hemodialysis unit. Nephrol Dial Transplant 1992;7: 981-982.
37. Busch MP, Wilber JC, Johnson P, Tobler L, Evans CS: Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992;32:420-425.
38. Wang JT, Wang TH, Sheu JC, Lin SM, Chen DS: Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992;30:750-753.
39. Cuypers HTM, Bresters D, Winkel IN, Reesink HW, Wiener AJ, Houghton M, van der Poel CL, Lelie WPN: Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 1992;30: 3220-3224.
40. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Di Filippo S, Erba G, Pagano A, Locatelli F: Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: A cross-sectional study. Clin Nephrol 1995;44:49-55.
41. Bukh J, Purcell RH, Miller RH: Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 1992;89:187-191.
42. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-724.
43. Okuda K, Hayashi H, Kobayashi S, Irie Y: Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995;23:28-31.
44. Niu MT, Alter MJ, Kristensen C, Margolis H: Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19: 345-352.
45. Gilli P, Moretti M, Soffritti S, Marchi N, Malacarne F, Bedani PL, de Paoli Vitali E, Fiocchi O, Menini C: Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990;13:737-741.
46. Sampietro M, Graziani G, Badalamenti S, Salvadori S, Caldarelli R, Como G, Fiorelli G: Detection of hepatitis C virus (HCV) in dialysate and in blood ultrafiltrate of HCV-positive patients. Nephron 1994;68:140.
47. Hung KY, Chen WJ, Yang CS, Lee SH, Wu DJ: Hepatitis B and C in hemodialysis patients. Dial Transplant 1995;24:135-139.
48. Rosen HR, Friedman LS, Martin P: Hepatitis C in renal dialysis and transplant patients. Viral Hepatitis Rev 1996;2:97-110.
49. MMWR Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health care settings. JAMA 1988;260:462-465.